These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22249525)

  • 1. Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits.
    Turek J; Ebetino FH; Lundy MW; Sun S; Kashemirov BA; McKenna CE; Gallant MA; Plotkin LI; Bellido T; Duan X; Triffitt JT; Russell RG; Burr DB; Allen MR
    Calcif Tissue Int; 2012 Mar; 90(3):202-10. PubMed ID: 22249525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone tissue aging affects mineralization of cement lines.
    Milovanovic P; Vom Scheidt A; Mletzko K; Sarau G; Püschel K; Djuric M; Amling M; Christiansen S; Busse B
    Bone; 2018 May; 110():187-193. PubMed ID: 29427789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-morphological properties of osteons reveal changes in cortical bone stability during aging, osteoporosis, and bisphosphonate treatment in women.
    Bernhard A; Milovanovic P; Zimmermann EA; Hahn M; Djonic D; Krause M; Breer S; Püschel K; Djuric M; Amling M; Busse B
    Osteoporos Int; 2013 Oct; 24(10):2671-80. PubMed ID: 23632826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo.
    Roelofs AJ; Stewart CA; Sun S; Błażewska KM; Kashemirov BA; McKenna CE; Russell RG; Rogers MJ; Lundy MW; Ebetino FH; Coxon FP
    J Bone Miner Res; 2012 Apr; 27(4):835-47. PubMed ID: 22228189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
    Russell RG; Watts NB; Ebetino FH; Rogers MJ
    Osteoporos Int; 2008 Jun; 19(6):733-59. PubMed ID: 18214569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of bisphosphonate treatment on the biochemical and cellular events during bone remodelling in response to microinjury stimulation.
    Mulcahy LE; Curtin CM; McCoy RJ; O'Brien FJ; Taylor D; Lee TC; Duffy GP
    Eur Cell Mater; 2015 Nov; 30():271-81. PubMed ID: 26614482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.
    Ma YL; Zeng Q; Donley DW; Ste-Marie LG; Gallagher JC; Dalsky GP; Marcus R; Eriksen EF
    J Bone Miner Res; 2006 Jun; 21(6):855-64. PubMed ID: 16753016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits.
    Vrahnas C; Buenzli PR; Pearson TA; Pennypacker BL; Tobin MJ; Bambery KR; Duong LT; Sims NA
    Calcif Tissue Int; 2018 Dec; 103(6):625-637. PubMed ID: 30019315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate.
    Wen D; Qing L; Harrison G; Golub E; Akintoye SO
    Oral Dis; 2011 May; 17(4):427-32. PubMed ID: 21122034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteocyte density in aging subjects is enhanced in bone adjacent to remodeling haversian systems.
    Power J; Loveridge N; Rushton N; Parker M; Reeve J
    Bone; 2002 Jun; 30(6):859-65. PubMed ID: 12052454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits.
    Mashiba T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    Bone; 2001 May; 28(5):538-47. PubMed ID: 11344054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and menopause-related bone loss compromise cortical and trabecular microstructure.
    Seeman E
    J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1218-25. PubMed ID: 23833200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages.
    Roelofs AJ; Thompson K; Ebetino FH; Rogers MJ; Coxon FP
    Curr Pharm Des; 2010; 16(27):2950-60. PubMed ID: 20722616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates: how do they work?
    Papapoulos SE
    Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):831-47. PubMed ID: 19028359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
    Plotkin LI; Bivi N; Bellido T
    Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.
    Allen MR; Kubek DJ; Burr DB
    J Bone Miner Res; 2010 Jan; 25(1):98-105. PubMed ID: 19580463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding kinetics of a fluorescently labeled bisphosphonate as a tool for dynamic monitoring of bone mineral deposition in vivo.
    Tower RJ; Campbell GM; Müller M; Will O; Glüer CC; Tiwari S
    J Bone Miner Res; 2014 Sep; 29(9):1993-2003. PubMed ID: 24644087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.
    Bagi CM; Volberg M; Moalli M; Shen V; Olson E; Hanson N; Berryman E; Andresen CJ
    Anat Rec (Hoboken); 2007 Aug; 290(8):1005-16. PubMed ID: 17610276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
    Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
    Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.